Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) EBT Margin (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed EBT Margin for 2 consecutive years, with 5514.74% as the latest value for Q1 2024.

  • For Q1 2024, EBT Margin changed N/A year-over-year to 5514.74%; the TTM value through Dec 2024 reached 24675.3%, changed N/A, while the annual FY2024 figure was 26045.02%, 2595948.0% down from the prior year.
  • EBT Margin hit 5514.74% in Q1 2024 for Artiva Biotherapeutics, down from 563.87% in the prior quarter.
  • Across five years, EBT Margin topped out at 563.87% in Q4 2023 and bottomed at 5514.74% in Q1 2024.